OX40 engagement depletes intratumoral Tregs via activating FcγRs, leading to antitumor efficacy (Q44805706)

6 December 2017

OX40 engagement depletes intratumoral Tregs via activating FcγRs, leading to antitumor efficacy (English)

1 reference

6 December 2017

Yannick Bulliard

1

1 reference

6 December 2017

Rose Jolicoeur

2

1 reference

6 December 2017

Jimin Zhang

3

1 reference

6 December 2017

Glenn Dranoff

4

1 reference

6 December 2017

Nicholas S Wilson

5

1 reference

6 December 2017

Jennifer L Brogdon

6

1 reference

6 December 2017

15 April 2014

1 reference

Immunology & Cell Biology

6 December 2017

1 reference

6 December 2017

92

1 reference

6 December 2017

6

1 reference

6 December 2017

475-480

1 reference

Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells

6 December 2017

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

Modulation of GITR for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

CD8+ T cells: GITR matters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

Signaling through OX40 enhances antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

Cancer immunotherapy comes of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

An Fcγ receptor-dependent mechanism drives antibody-mediated target-receptor signaling in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

Inhibitory Fcγ receptor engagement drives adjuvant and anti-tumor activities of agonistic CD40 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

FcγRΙΙB controls the potency of agonistic anti-TNFR mAbs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

The crystal structure of the costimulatory OX40-OX40L complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

Depleting tumor-specific Tregs at a single site eradicates disseminated tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

Fcgamma receptors as regulators of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

Fcγ receptors enable anticancer action of proapoptotic and immune-modulatory antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

Pancreatic islet xenograft survival in mice is extended by a combination of alpha-1-antitrypsin and single-dose anti-CD4/CD8 therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

The perspective of immunotherapy: new molecules and new mechanisms of action in immune modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

Fcgamma receptors: old friends and new family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

Fc-mOX40L fusion protein produces complete remission and enhanced survival in 2 murine tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

Science gone translational: the OX40 agonist story

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

Glucocorticoid-induced TNFR-related protein lowers the threshold of CD28 costimulation in CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

inferred from DOI database lookup

7 January 2021

based on heuristic

Engagement of the OX-40 receptor in vivo enhances antitumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.26

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/ICB.2014.26

1 reference

release_owf7kpochjhtxglyp3g57iwsmi

6 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/owf7kpochjhtxglyp3g57iwsmi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference